Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Yin

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation]Xue-Rong Deng, Han-Yun Ren, Xi-Nan Cen, et al.
Frontiers in Immunology|March 14, 2022
Low-Dose 5-Aza and DZnep Alleviate Acute Graft-<i>Versus</i>-Host Disease With Less Side Effects Through Altering T-Cell DifferentiationQing Ya Wang, Hui Hui Liu, Yu Jun Dong, et al.
Fish & Shellfish Immunology|September 15, 2024
A molecular mechanism underlies grass carp (Ctenopharyngodon idella) TARBP2 regulating PKR-mediated cell apoptosisMiao-Miao Li, Chang-Bai Tao, Mei-Feng Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 13, 2011
[Application of SPECT/PET to 70 patients with lymphoma: monitoring response to therapy]Hui Yao, Xi-Nan Cen, Ze-Yin Liang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 23, 2010
[Quantitative monitoring of mononucleated cell Epstein-Barr virus (EBV)-DNA for predicting EBV associated lymphoproliferative disorders after stem cell transplantation.]Li-Hong Wang, Han-Yun Ren, Yu-Hua Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 15, 2013
[Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation]Ze-Yin Liang, Han-Yun Ren, Xi-Nan Cen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 12, 2012
[Clinical investigation of primary amyloidosis with autologous hematopoietic stem cell transplantation]Zhi-xiang Qiu, Mang-ju Wang, Li-hong Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2010
[Efficacy analysis of sequential treatment with chemotherapy, ATRA and As(2)O(3) for acute promyelocytic leukemia]Xiang-Juan Ma, Han-Yun Ren, Xi-Nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2019
[Preliminary Study on the Characteristic of Plasma Cytokine Profiles in Patients with Idiopathic Multicentric Castleman Diseases]Ning Ma, Hui-Hui Liu, Wei Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 1, 2013
[Combination of rituximab with autologous peripheral blood stem cell transplantation for treatment of diffuse large B-cell lymphoma: a single-center experience]Ze-yin Liang, Xi-nan Cen, Zhi-xiang Qiu, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation]Xue-Rong Deng, Han-Yun Ren, Xi-Nan Cen, et al.
Frontiers in Immunology|March 14, 2022
Low-Dose 5-Aza and DZnep Alleviate Acute Graft-<i>Versus</i>-Host Disease With Less Side Effects Through Altering T-Cell DifferentiationQing Ya Wang, Hui Hui Liu, Yu Jun Dong, et al.
Fish & Shellfish Immunology|September 15, 2024
A molecular mechanism underlies grass carp (Ctenopharyngodon idella) TARBP2 regulating PKR-mediated cell apoptosisMiao-Miao Li, Chang-Bai Tao, Mei-Feng Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 13, 2011
[Application of SPECT/PET to 70 patients with lymphoma: monitoring response to therapy]Hui Yao, Xi-Nan Cen, Ze-Yin Liang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 23, 2010
[Quantitative monitoring of mononucleated cell Epstein-Barr virus (EBV)-DNA for predicting EBV associated lymphoproliferative disorders after stem cell transplantation.]Li-Hong Wang, Han-Yun Ren, Yu-Hua Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 15, 2013
[Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation]Ze-Yin Liang, Han-Yun Ren, Xi-Nan Cen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 12, 2012
[Clinical investigation of primary amyloidosis with autologous hematopoietic stem cell transplantation]Zhi-xiang Qiu, Mang-ju Wang, Li-hong Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2010
[Efficacy analysis of sequential treatment with chemotherapy, ATRA and As(2)O(3) for acute promyelocytic leukemia]Xiang-Juan Ma, Han-Yun Ren, Xi-Nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2019
[Preliminary Study on the Characteristic of Plasma Cytokine Profiles in Patients with Idiopathic Multicentric Castleman Diseases]Ning Ma, Hui-Hui Liu, Wei Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 1, 2013
[Combination of rituximab with autologous peripheral blood stem cell transplantation for treatment of diffuse large B-cell lymphoma: a single-center experience]Ze-yin Liang, Xi-nan Cen, Zhi-xiang Qiu, et al.
Pageof 9